Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Damei Wang
Introduction
Damei Wang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin formulations. His innovative approach has led to advancements that benefit patients requiring insulin therapy.
Latest Patents
Damei Wang holds a patent for a method for preparing insulin glargine crystals. This method involves crystallizing insulin glargine at a pH of 7.0-9.0 in a crystallization solution that includes a recombinant insulin glargine, an organic solvent of 10-30% concentration by volume, a zinc compound, a phenol derivative, a salt, and an organic acid. This patent showcases his expertise in pharmaceutical chemistry and his commitment to improving diabetes treatment.
Career Highlights
Damei Wang is currently employed at Gan & Lee Pharmaceuticals, a company known for its focus on diabetes care and insulin products. His work at this organization has allowed him to collaborate with other talented professionals in the field. His contributions have been instrumental in advancing the company's research and development efforts.
Collaborations
Damei Wang has worked alongside notable colleagues such as Wenjie Li and Jinlei Zhang. Their collaborative efforts have fostered an environment of innovation and creativity, leading to significant advancements in their projects.
Conclusion
Damei Wang's contributions to the field of pharmaceuticals, particularly through his patent for insulin glargine crystals, highlight his role as an influential inventor. His work continues to impact the lives of many individuals requiring insulin therapy.